Add BrightSurf on Google Email

Massachusetts General Hospital


Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

Researchers identified Wnt7b as a determinant of resistance to immune checkpoint blockers in glioblastoma and developed a combination therapy with WNT974 that sensitizes GBM to anti-PD1 therapy, improving anti-tumor immunity. This approach offers a promising new therapeutic avenue for glioblastoma patients.

SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 18, 2025

Research spotlight: organoids could make gene therapy trials safer by identifying hidden risks early on

Researchers used human stem cell-derived kidney organoids to test the safety of gene editing delivered by AAV, a common tool in clinical trials. The study found that AAV2 caused significant harm to kidney cells through the NFκB pathway, but an existing drug was able to prevent this damage without interfering with gene delivery.

SourceMassachusetts General Hospital·JournalSignal Transduction and Targeted Therapy·TypeExperimental study·DateAug 18, 2025

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Two reviews by Drs Komaroff and Dantzer highlight the biological problems causing long-lasting symptoms in Long COVID and ME/CFS, including inflammation, energy production issues, and immune system dysregulation. These conditions are grouped under post-acute infection syndromes, which may be treated with targeted therapies.

SourceMassachusetts General Hospital·JournalCell Reports·DateAug 1, 2025

‘Alzheimer’s in dish’ model shows promise for accelerating drug discovery

Researchers from Mass General Brigham developed an algorithm to assess the accuracy of 3D models of Alzheimer's disease, identifying crucial shared pathways and confirming the model's potential for accelerating drug discovery. The study found that a clinical p38 MAPK inhibitor is highly effective at reducing AD pathology in a dish.

SourceMassachusetts General Hospital·JournalNeuron·TypeObservational study·DateNov 27, 2024

Research Spotlight: The public health impact of the FDA’s request for additional safety data on cytisine for tobacco cessation

A new study finds that making cytisine available immediately could lead to approximately 71,000 more people quitting smoking over one year and maintaining long-term abstinence. This would produce over 500,000 additional life-years. A delay in approval by the FDA may result in reduced population-level gains of up to 10,000 life-years.

SourceMassachusetts General Hospital·JournalJAMA Health Forum·TypeComputational simulation/modeling·DateSep 9, 2024

Research Spotlight: association of statin, metformin, and aspirin use with hepatocellular carcinoma in the all of us research program

A recent study published in Gastro Hep Advances found that statin use was associated with a reduced risk of hepatocellular carcinoma (HCC). The research, conducted using data from the All of Us Research Program, suggests that lipophilic statins may be an effective strategy for chemoprevention in HCC. Patients with indications for stati...

SourceMassachusetts General Hospital·JournalGastro Hep Advances·TypeData/statistical analysis·DateSep 9, 2024

Increasing clinicians’ knowledge about climate change’s impact on health and healthcare sustainability

A recent survey-based study found that physicians at Massachusetts General Hospital who completed climate change-focused educational modules showed significant improvements in their knowledge and attitudes towards the topic. The majority of participants believed that education on climate change's health effects was important and welcom...

SourceMassachusetts General Hospital·JournalJAMA Network Open·TypeSurvey·DateAug 8, 2024

Research spotlight: Machine learning classification of functional neurological disorder

A machine learning algorithm was trained to predict individuals with functional neurological disorder (FND) by analyzing their brain structure. The algorithm achieved significant above-chance accuracy in classifying FND participants against healthy controls and psychiatric samples, highlighting the importance of considering both brain ...

SourceMassachusetts General Hospital·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeImaging analysis·DateJul 23, 2024

Research spotlight: Health care discrimination and care avoidance due to patient-clinician identity discordance among sexual and gender minority adults

A study analyzing national data reveals that SGM adults are more likely to avoid healthcare due to perceived differences in identity with their clinicians. The study highlights the importance of diversifying the healthcare workforce and preventing discrimination against SGM patients.

SourceMassachusetts General Hospital·JournalThe Annals of Family Medicine·DateJul 22, 2024

Automated appointment scheduling and reminder messages may improve post-partum health and well-being for those with chronic health conditions

A new study found that an intervention involving automated appointment scheduling and reminder messages can increase primary care visits by 19 percentage points and improve screening tests and services. This low-cost intervention may help bridge the gap in postpartum care for individuals with chronic health conditions.

SourceMassachusetts General Hospital·JournalJAMA Network Open·TypeExperimental study·DateJul 16, 2024

Research spotlight: Patterns and prognostications in immune-related adverse events from immunotherapy treatment

A study comprehensively evaluated occurrence patterns of immune-related adverse events, including those affecting single organs and multiple organs. Researchers found that most events tend to co-occur and identified seven patient clusters with different development patterns, which were associated with improved or worsened survival outc...

SourceMassachusetts General Hospital·JournalThe Lancet Oncology·TypeData/statistical analysis·DateJul 16, 2024

Research spotlight: The impact of tobacco smoking and smoking cessation on the life expectancy of people with HIV in South Africa

Research found that smoking decreases life expectancy of HIV patients by 3-6 years, but smoking cessation can regain up to 5 years. Integrating tobacco cessation interventions into HIV care could substantially improve life expectancy for this population.

SourceMassachusetts General Hospital·JournalJournal of the International AIDS Society·TypeComputational simulation/modeling·DateJul 15, 2024

Clinicians report success with first test of drug in a patient with life-threatening blood clotting disorder

A team led by Massachusetts General Hospital used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting. The drug, recombinant ADAMTS13, reversed the disease process in a patient with an extremely severe form of iTTP.

SourceMassachusetts General Hospital·JournalNew England Journal of Medicine·TypeExperimental study·DateMay 17, 2024

Study identifies signs of repeated blast-related brain injury in active-duty United States Special Operations Forces

Researchers found structural, functional, and neuroimmune brain alterations associated with higher blast exposure, impacting health-related quality of life. The frontal lobe's rostral anterior cingulate cortex (rACC) was particularly sensitive to blast waves.

SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·TypeImaging analysis·DateApr 22, 2024

Researchers find that accelerated aging biology in the placenta contributes to a rare form of pregnancy-related heart failure

Researchers found that accelerated aging biology in the placenta contributes to peripartum cardiomyopathy (PPCM), a rare form of pregnancy-related heart failure. The study identifies underlying aging-related biology contributing to maternal heart failure and provides evidence from both patients and animal models.

SourceMassachusetts General Hospital·JournalScience Translational Medicine·TypeExperimental study·DateApr 17, 2024

Physical activity reduces stress-related brain activity to lower cardiovascular disease risk

A new study published in the Journal of the American College of Cardiology found that physical activity lowers cardiovascular disease risk by reducing stress-related signaling in the brain. Participants who met physical activity recommendations had a 23% lower risk of developing cardiovascular disease compared to those who did not.

SourceMassachusetts General Hospital·JournalJournal of the American College of Cardiology·TypeObservational study·DateApr 15, 2024

Mass General study identifies an AI model that can accurately assess PTSD in postpartum women

A new AI model can accurately screen for post-traumatic stress disorder (PTSD) in postpartum women, offering a potential solution for early intervention and preventing progression of the disorder. The study collected narrative accounts from 1,295 women and showed the model's superiority in identifying PTSD cases.

SourceMassachusetts General Hospital·JournalScientific Reports·TypeExperimental study·DateApr 11, 2024

Study finds benefits in prescribing alcohol use disorder medications upon discharge from alcohol-related hospitalizations

A recent study published in JAMA Network Open found that adults hospitalized for alcohol-related reasons who received a prescription for an alcohol use disorder medication at discharge had a lower risk of returning to the hospital within 30 days. This includes reduced emergency room visits and readmissions, with patients having an 18% ...

SourceMassachusetts General Hospital·JournalJAMA Network Open·DateMar 29, 2024

A combination of approved drugs enhances the delivery of anti-bacterial medications to treat tuberculosis

Researchers at Massachusetts General Hospital successfully repurposed approved drugs to improve drug delivery to tuberculosis bacteria, promoting anti-bacterial host responses and improving health outcomes. The study found that combining bevacizumab and losartan enhanced TB drug delivery and reduced bacterial burden in rabbits with TB.

SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·DateMar 27, 2024